719 related articles for article (PubMed ID: 18482780)
1. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
[TBL] [Abstract][Full Text] [Related]
2. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
[TBL] [Abstract][Full Text] [Related]
3. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions.
Spásová I; Petera J
Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295
[TBL] [Abstract][Full Text] [Related]
4. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
[TBL] [Abstract][Full Text] [Related]
5. [Endoluminal HDR brachytherapy in the palliative treatment of patients with the recurrence of a non-small-cell bronchial carcinoma after prior radiotherapy].
Micke O; Prott FJ; Schäfer U; Wagner W; Pötter R; Willich N
Strahlenther Onkol; 1995 Oct; 171(10):554-9. PubMed ID: 8571174
[TBL] [Abstract][Full Text] [Related]
6. High dose rate intraluminal brachytherapy in the treatment of malignant airway obstructions.
Petera J; Spásová I; Neumanová R; Skricková J; Salajka F; Hrazdírová A; Kaplanová J; Coupková H; Coupek P; Kucera M
Neoplasma; 2001; 48(2):148-53. PubMed ID: 11478697
[TBL] [Abstract][Full Text] [Related]
7. Combination of interventional pulmonology techniques (Nd:YAG laser resection and brachytherapy) with external beam radiotherapy in the treatment of lung cancer patients with Karnofsky Index < or =50.
Canak V; Zarić B; Milovancev A; Jovanović S; Budisin E; Sarcev T; Lalić N; Nisević V; Balaban G
J BUON; 2006; 11(4):447-56. PubMed ID: 17309176
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life.
Mallick I; Sharma SC; Behera D
Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949
[TBL] [Abstract][Full Text] [Related]
9. Irradiated volume and the risk of fatal hemoptysis in patients submitted to high dose-rate endobronchial brachytherapy.
Carvalho Hde A; Gonçalves SL; Pedreira W; Gregório MG; de Castro I; Aisen S
Lung Cancer; 2007 Mar; 55(3):319-27. PubMed ID: 17129634
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of endobronchial brachytherapy: A curative treatment?
Hennequin C; Bleichner O; Trédaniel J; Quero L; Sergent G; Zalcman G; Maylin C
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):425-30. PubMed ID: 17084547
[TBL] [Abstract][Full Text] [Related]
11. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
[TBL] [Abstract][Full Text] [Related]
12. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer].
Makarewicz R
Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625
[TBL] [Abstract][Full Text] [Related]
13. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
14. The role of palliative radiotherapy in locally advanced non-small cell lung cancer.
Cetingoz R; Kentli S; Uruk O; Demirtas E; Sen M; Kinay M
Neoplasma; 2001; 48(6):506-10. PubMed ID: 11949846
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue.
Tendulkar RD; Fleming PA; Reddy CA; Gildea TR; Machuzak M; Mehta AC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):701-6. PubMed ID: 17904764
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma.
Corner C; Bryant L; Chapman C; Glynne-Jones R; Hoskin PJ
Brachytherapy; 2010; 9(1):66-70. PubMed ID: 19846349
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients.
Aumont-le Guilcher M; Prevost B; Sunyach MP; Peiffert D; Maingon P; Thomas L; Williaume D; Begue M; Lerouge D; Campion L; Mahe MA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1112-6. PubMed ID: 20510543
[TBL] [Abstract][Full Text] [Related]
18. [The polycentric multiple arc complanar technic, or telebrachytherapy. A 4-year experience (an innovative way for the local control of solid neoplasms)].
Polico R; Stea L; Antonello M; Princivalli M; Marchetti C; Busetto M; Schiavon S; Pizzi G
Radiol Med; 1995; 90(1-2):113-23. PubMed ID: 7569075
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
[TBL] [Abstract][Full Text] [Related]
20. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
